Elutia (ELUT) Research & Development (2019 - 2026)
Elutia (ELUT) reported Research & Development of $2.0 million for Q1 2026, up 98.29% on a YoY basis from $995000.0 in Q1 2025, and up 557.67% sequentially from $300000.0 in Q4 2025.
Elutia (ELUT) Research & Development (2019 - 2026) Analysis & Trends
Elutia (ELUT) has 8 years of Research & Development data on file, last reported at $2.0 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 98.29% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $5.3 million (up 179.79% YoY), and the FY2025 full-year result was $4.2 million, up 38.86% from the prior year.
- Research & Development advanced to $2.0 million in Q1 2026, from $300000.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $4.8 million in Q1 2022 to a low of -$5.9 million in Q4 2022.
- A 5-year average of $1.4 million and a median of $1.5 million in 2025 frame the typical range for Research & Development.
- Peak annual rise in Research & Development reached 180.12% in 2022, while the deepest fall reached 276.1% in 2022.
- Tracing ELUT's Research & Development over 5 years: stood at -$5.9 million in 2022, then soared by 123.26% to $1.4 million in 2023, then tumbled by 157.34% to -$793000.0 in 2024, then jumped by 137.83% to $300000.0 in 2025, then soared by 557.67% to $2.0 million in 2026.
- Business Quant data shows ELUT's Research & Development at $2.0 million in Q1 2026, $300000.0 in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Elutia | 39.99 Mn | 11.50 Mn | 1.80 Mn | 1.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.97 Mn |
| Dec 31, 2025 | 300,000.00 |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 995,000.00 |
| Dec 31, 2024 | -793,000.00 |
| Sep 30, 2024 | 702,000.00 |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 2.80 Mn |
| Jun 30, 2023 | 3.02 Mn |
| Mar 31, 2023 | 4.69 Mn |
| Dec 31, 2022 | -5.95 Mn |
| Sep 30, 2022 | 1.72 Mn |
| Jun 30, 2022 | 2.62 Mn |
| Mar 31, 2022 | 4.82 Mn |
| Dec 31, 2021 | 3.38 Mn |
| Sep 30, 2021 | 2.29 Mn |
| Jun 30, 2021 | 1.88 Mn |